vimarsana.com

Latest Breaking News On - F evt de0005664809 - Page 1 : vimarsana.com

Evotec presents sustainability strategy

EQS-News: Evotec SE / Key word: Miscellaneous Evotec presents sustainability strategy 05.06.2023 / 07:30 CET/CEST The issuer is solely responsible for the content of this. | June 5, 2023

Hinnerk rohwedderVolker braunWerner lanthalerGabriele hansenSustainable development goalHead of global corporate communicationsGlobal corporate communicationsCompany sustainabilityEvotec se frankfurt stock exchangeFrankfurt stock exchangeCapital marketsCapital markets dayUnited nationsEvotec biologicChief executive officerGlobal investor relations

Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide. | May 11, 2023

United statesEssener bogenNotification of major holdingsT rowe price global growth stock fundT rowe price international funds incT rowe price european stock fundT rowe price international stock fundDistribution servicesT rowe price overseas stock fundT rowe price international discovery fundRights announcementVoting rights announcementEigen campusEntity identifierPrice international fundsRowe price international funds

Evotec : EVT801 pre-clinical data published in peer-reviewed cancer research journal

Sydney, Australia, 01 December 2022: Evotec partner Kazia Therapeutics Limited , an oncology-focused drug development company, announced the publication of positive. | December 2, 2022

United statesNew south walesKazia therapeutics limitedUniversity cancer institute of toulouseCancer research communicationsAmerican association of cancer researchMichael paillasseUniversity cancer instituteAmerican associationCancer researchEvotec se stock exchangePress releaseF evt de0005664809

vimarsana © 2020. All Rights Reserved.